SureTouch can be compared to Hans Christian Anderson’s classic fairytale, “The Princess and the Pea.” The SureTouch sensor works by detecting differences in hardness under layers of softer tissue, much like the princess was able to detect a pea underneath multiple soft mattresses.

Inspired by his mother’s battle with breast cancer, Dr. Jae Son, an entrepreneur and inventor with an Engineering Sciences Ph.D. from Harvard University, founded Medical Tactile in 2002 with the mission of delivering more accurate breast examinations without pain or radiation at lower cost using SureTouch. 

SureTouch is an FDA-cleared (FDA #K010514) technological breakthrough that provides a safe, ultra-sensitive and reliable clinical breast examination with immediate, objective, digitized results for patients and doctors. The sensitivity, accuracy and immediacy of the breast screening results provided by SureTouch enables patients and doctors to take potentially life-saving action in the event of an abnormality.  

  • The SureTouch system is comprised of a wireless sensor, a touch screen display, and a cloud-based SureTouch network. The hand-held SureTouch sensor glides gently across the breast and generates a multi-dimensional color image on the touch screen display. SureTouch allows the provider to view and document the size, shape, hardness and location of any breast abnormality. Conversely, the technology also shows the absence of any abnormality thus providing peace of mind to both the patient and provider that the breast is cancer-free.

See how SureTouch works in the Doctor's Show

 

SureTouch utilizes tactile-sensing technology, originally developed at Harvard University, to capture the sense of touch which has been used for cancer detection for thousands of years and accounts for 80% of breast cancers found today. Breasts are examined quickly and comfortably without compression or radiation. The patented, hand-held, SureTouch sensor glides easily over the entire breast and underarm area. Its 192 sensing elements capture and document the shape, location, size and hardness of breast lesions.  Any breast lesions are displayed on the SureTouch console screen as two- and three-dimensional full-color images. Because images are digitally stored for future reference, results can be tracked and compared for changes over time.